Chimeric Antigen Receptor T Cells as Senolytic and Antifibrotic Therapy

HepatologyVolume 73, Issue 3 p. 1227-1229 Hepatology Elsewhere Chimeric Antigen Receptor T Cells as Senolytic and Antifibrotic Therapy Aashreya Ravichandra M.A., Aashreya Ravichandra M.A. Department of Medicine, Columbia University, New York, NYSearch for more papers by this authorAveline Filliol Ph.D., Aveline Filliol Ph.D. Department of Medicine, Columbia University, New York, NYSearch for more papers by this authorRobert F. Schwabe M.D., Robert F. Schwabe M.D. Department of Medicine, Columbia University, New York, NY Institute of Human Nutrition, Columbia University, New York, NYSearch for more papers by this author Aashreya Ravichandra M.A., Aashreya Ravichandra M.A. Department of Medicine, Columbia University, New York, NYSearch for more papers by this authorAveline Filliol Ph.D., Aveline Filliol Ph.D. Department of Medicine, Columbia University, New York, NYSearch for more papers by this authorRobert F. Schwabe M.D., Robert F. Schwabe M.D. Department of Medicine, Columbia University, New York, NY Institute of Human Nutrition, Columbia University, New York, NYSearch for more papers by this author First published: 14 October 2020 https://doi.org/10.1002/hep.31596Citations: 2 Potential conflict of interest: Nothing to report. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume73, Issue3March 2021Pages 1227-1229 RelatedInformation